textabstractBackground It is important to gain insight into opportunities for secondary prevention of cardiovascular disease. Our aim was to investigate levels and trends in cardiovascular risk factors and drug treatment in Dutch post-myocardial infarction (MI) patients between 2002 and 2006 and to make comparisons with the EUROASPIRE surveys (1999-2007). Methods We analysed data from 4837 post-MI patients (aged 69 years, 78% men) from 32 Dutch hospitals, using baseline cross-sectional data from the Alpha Omega Trial. Results Between 2002 and 2006, significant declines were found in the prevalence of smoking (23% to 16%, p<0.001), hypercholesterolaemia (≥5 mmol/l; 54% to 27%, p<0.0001) and hypertension (≥140/90 mmHg; 58% to 48%, p<0.001). T...
Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular ri...
Background: Target values for cardiovascular risk factors in patients with coronary heart disease (C...
Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular ri...
Background It is important to gain insight into opportunities for secondary prevention of cardiovasc...
Background It is important to gain insight into opportunities for secondary prevention of cardiovasc...
Background It is important to gain insight into opportunities for secondary prevention of cardiovasc...
Contains fulltext : 108511.pdf (publisher's version ) (Open Access
Objective: We examined levels and trends in cardiovascular risk factors and drug treatment in myocar...
Objective: We examined levels and trends in cardiovascular risk factors and drug treatment in myocar...
Background: Favourable trends in risk factor levels in the general population may partly explain the...
Secondary preventive drug treatment in patients aged >= 60 years with a history of myocardial infarc...
BACKGROUND: Favourable trends in risk factor levels in the general population may partly explain the...
Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial inf...
We set out to determine what proportion of the mortality decline from 1997 to 2007 in coronary heart...
Abstract Background Favourable trends in risk factor levels in the general population may partly exp...
Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular ri...
Background: Target values for cardiovascular risk factors in patients with coronary heart disease (C...
Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular ri...
Background It is important to gain insight into opportunities for secondary prevention of cardiovasc...
Background It is important to gain insight into opportunities for secondary prevention of cardiovasc...
Background It is important to gain insight into opportunities for secondary prevention of cardiovasc...
Contains fulltext : 108511.pdf (publisher's version ) (Open Access
Objective: We examined levels and trends in cardiovascular risk factors and drug treatment in myocar...
Objective: We examined levels and trends in cardiovascular risk factors and drug treatment in myocar...
Background: Favourable trends in risk factor levels in the general population may partly explain the...
Secondary preventive drug treatment in patients aged >= 60 years with a history of myocardial infarc...
BACKGROUND: Favourable trends in risk factor levels in the general population may partly explain the...
Secondary preventive drug treatment in patients aged > or =60 years with a history of myocardial inf...
We set out to determine what proportion of the mortality decline from 1997 to 2007 in coronary heart...
Abstract Background Favourable trends in risk factor levels in the general population may partly exp...
Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular ri...
Background: Target values for cardiovascular risk factors in patients with coronary heart disease (C...
Background The first and second EUROASPIRE surveys showed high rates of modifiable cardiovascular ri...